Tumor-selective stabilization of RNA is employed as a new approach to engineer viruses that preferentially replicate in cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
©Rebecca Henretta
References
Ahmed, A. et al. Nat. Biotechnol. 21, 771–777 (2003).
Smith, R. et al. Cancer 9, 1211–1218 (1956).
Kirn, D. Oncogene 19, 6660–6669 (2000).
Chiocca, E.A. Nat. Rev. Cancer 2, 938–951 (2002).
Mullen, J.T. & Tanabe, K.K. The Oncologist 7, 106–119 (2002).
Knipe, D.M. & Howley, P.M. (eds.). Fields Virology (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, USA, 2001).
Raghavan, A. et al. Nucleic Acids Res. 30, 5529–5538 (2002).
Cumming, S.A. J. Virol. 76, 5993–6003 (2002).
Nabors, L.B., Gillespie, G.Y., Harkins, L. & King, P.H. Cancer Res. 61, 2154–2161 (2001).
Wein, M.L., Wu, J.T. & Kirn, D.H. Cancer Res. 63, 1317–1324 (2003).
Harrison, D. et al. Hum. Gene Ther. 12, 1323–1332 (2001).
Wakimoto, H., Johnson, P.R., Knipe, D.M. & Chiocca, E.A. Gene Ther. 10, 983–999 (2003).
Toth, K. et al. Mol. Ther. 7, 435–437 (2003).
Freytag, S. et al. Cancer Res. 62, 4968–4976 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aguilar-Cordova, E. Vectorology recapitulates virology—will it capitulate oncology?. Nat Biotechnol 21, 756–757 (2003). https://doi.org/10.1038/nbt0703-756
Issue Date:
DOI: https://doi.org/10.1038/nbt0703-756
